Clinical Trial Update: Clinical Trial of TQB2825 Injection Combined With Chemotherapy in Subjects With Diffuse Large B-cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating TQB2825 injection in combination with chemotherapy for diffuse large B-cell lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• TQB2825

Snippet

Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. | Conditions: Diffuse Large Cell B-lymphoma | Phase 2 | Status: RECRUITING